Autopsy report · NCT02826681

Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia

“Lack of enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year before it started.
• Ran for about 5 years before it stopped.
• 70 participants enrolled.
• Results were posted on the registry 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

American Regent, Inc.

Sponsor type

Industry

Conditions

Restless Legs Syndrome (RLS)

Interventions

Injectafer® (Ferric Carboxymaltose - FCM); Placebo (Normal Saline)

Participants

70

Sites

8

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.